Robert A. Stern, PhD
Professor
Boston University School of Medicine
Dept of Neurology

PhD, University of Rhode Island
MA, University of Rhode Island



As the Clinical Core Director of the NIA-funded Boston University Alzheimer’s Disease Center (BU ADC), I oversee a multidisciplinary group of talented scientists and clinicians and direct the center’s longitudinal research registry, as well as several NIH- and industry-funded diagnostic, prevention, and treatment trials. The major focus of my current research is on the long-term effects of repetitive head impacts in athletes, including the neuropathological, risk factors (genetic and head impact exposure), neuroimaging, biomarker development, and clinical diagnosis and descriptions of the neurodegenerative disease, chronic traumatic encephalopathy (CTE). Other areas of my current and recent research program include the diagnosis, risk factors, and treatment of cognitive decline and neuropsychiatric dysfunction in aging. I have also published extensively on the psychometric properties of many widely used tests in neuropsychology, as well as the use of various instruments and biomarkers in the differential diagnosis of neurodegenerative disease. In addition, I have developed several commonly used tests and instruments, including the Neuropsychological Assessment Battery (NAB). I have had leadership positions in several training programs, have mentored over 40 trainees, and play a key role in the professional development of junior faculty in the BU School of Medicine (BUSM) Neurology Department.

Professor
Boston University School of Medicine
Anatomy & Neurobiology


Professor
Boston University School of Medicine
Neurosurgery


Graduate Faculty (Primary Mentor of Grad Students)
Boston University School of Medicine, Division of Graduate Medical Sciences


Active Staff Privileges
Boston Medical Center
Neurology




Registry of Amyloid Positive Patients for Alzheimer's Disease Drug Research Trials ("RAmP" or 18F-AV-45-A25)
03/20/2017 - 03/19/2020 (PI)
Avid Radiopharmaceuticals, Inc.

A Randomized, Double-Blind, Placebo-Controlled and Delayed-Start Study of LY3314814 in Mild Alzheimer's Disease Dementia (The DAYBREAK Study)
10/24/2016 - 10/23/2018 (PI)
Eli Lilly and Company

An Open label, multicenter study evaluating the imaging characteristics of a follow up F-AV-1451 scan in subjects that participated in the confirmatory cohort of FV-AV-1451-A05
09/29/2016 - 09/28/2018 (PI)
Avid Radiopharmaceuticals, Inc.

A placebo-controlled, double-blind, parallel-group, bayesian adaptive randomization design and dose regimen-finding study to evaluate the safety tolerability and efficacy of BAN2401 in subjects with
02/01/2013 - 06/30/2018 (PI)
Eisai, Inc

An open label, multicenter study, evaluating the safety and imaging characteristics of 18F-AV-1451 in cognitively healthy volunteers, subjects with Mild Cognitive Impairment, and subjects with Alzheim
03/01/2014 - 05/31/2018 (PI)
Avid Radiopharmaceuticals, Inc.

A Phase 2 multi-center, randomized, double blind, placebo-controlled, parallel group study to evaluate the efficacy and safety of T-817MA in patients with mild to moderate Alzheimer's Disease (US202)
11/21/2013 - 05/31/2018 (PI)
The Regents of the University of Califor Toyama Chemical Co.

Magnetic Resonance Spectroscopy as a Biomarker for Chronic Traumatic Encephalopathy
05/01/2016 - 04/30/2018 (Co-PI)
NIH/National Institute of Neurological D
5F32NS096803-02

Tau PET Imaging for the USC Alzheimer's Therapeutic Research Institute (USC ATRI) A4 Trial (â??A4 TAUâ?)
10/01/2016 - 12/31/2017 (PI)
University of Southern California Fundation for NIH

Anti-Amyloid Treatment in Asymptomatic Alzheimer's Disease (A4 Study)
12/11/2015 - 12/10/2017 (PI)
University of Southern California Eli Lilly and Co

Chronic Traumatic Encephalopathy: Detection, Diagnosis, Course, and Risk Factors
12/15/2015 - 11/30/2017 (PI)
NIH/National Institute of Neurological D
5U01NS093334-02

Showing 10 of 39 results. Show All Results



Yr Title Project-Sub Proj Pubs
2017 Chronic Traumatic Encephalopathy: Detection, Diagnosis, Course, and Risk Factors 5U01NS093334-02 1
2016 Chronic Traumatic Encephalopathy: Detection, Diagnosis, Course, and Risk Factors 1U01NS093334-01 1
2013 Chronic Traumatic Encephalopathy: Clinical Presentation and Biomarkers 5R01NS078337-03 19
2013 OLDER BREAST CANCER PATIENTS: RISK FOR COGNITIVE DECLINE 5R01CA129769-05 28
2012 Chronic Traumatic Encephalopathy: Clinical Presentation and Biomarkers 5R01NS078337-02 19
2012 OLDER BREAST CANCER PATIENTS: RISK FOR COGNITIVE DECLINE 5R01CA129769-04 28
2012 Subclinical Hypothyroidism: Mood, Cognition and the effect of L-thyroxine treatme 5R01MH080295-05 24
2011 Chronic Traumatic Encephalopathy: Clinical Presentation and Biomarkers 1R01NS078337-01A1 19
2011 OLDER BREAST CANCER PATIENTS: RISK FOR COGNITIVE DECLINE 5R01CA129769-03 28
2011 Subclinical Hypothyroidism: Mood, Cognition and the effect of L-thyroxine treatme 5R01MH080295-04 24
Showing 10 of 21 results. Show All Results
Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.

  1. Sims R, van der Lee SJ, Naj AC, Bellenguez C, Badarinarayan N, Jakobsdottir J, Kunkle BW, Boland A, Raybould R, Bis JC, Martin ER, Grenier-Boley B, Heilmann-Heimbach S, Chouraki V, Kuzma AB, Sleegers K, Vronskaya M, Ruiz A, Graham RR, Olaso R, Hoffmann P, Grove ML, Vardarajan BN, Hiltunen M, Nöthen MM, White CC, Hamilton-Nelson KL, Epelbaum J, Maier W, Choi SH, Beecham GW, Dulary C, Herms S, Smith AV, Funk CC, Derbois C, Forstner AJ, Ahmad S, Li H, Bacq D, Harold D, Satizabal CL, Valladares O, Squassina A, Thomas R, Brody JA, Qu L, Sánchez-Juan P, Morgan T, Wolters FJ, Zhao Y, Garcia FS, Denning N, Fornage M, Malamon J, Naranjo MCD, Majounie E, Mosley TH, Dombroski B, Wallon D, Lupton MK, Dupuis J, Whitehead P, Fratiglioni L, Medway C, Jian X, Mukherjee S, Keller L, Brown K, Lin H, Cantwell LB, Panza F, McGuinness B, Moreno-Grau S, Burgess JD, Solfrizzi V, Proitsi P, Adams HH, Allen M, Seripa D, Pastor P, Cupples LA, Price ND, Hannequin D, Frank-García A, Levy D, Chakrabarty P, Caffarra P, Giegling I, Beiser AS, Giedraitis V, Hampel H, Garcia ME, Wang X, Lannfelt L, Mecocci P, Eiriksdottir G, Crane PK, Pasquier F, Boccardi V, Henández I, Barber RC, Scherer M, Tarraga L, Adams PM, Leber M, Chen Y, Albert MS, Riedel-Heller S, Emilsson V, Beekly D, Braae A, Schmidt R, Blacker D, Masullo C, Schmidt H, Doody RS, Spalletta G, Jr WTL, Fairchild TJ, Bossù P, Lopez OL, Frosch MP, Sacchinelli E, Ghetti B, Yang Q, Huebinger RM, Jessen F, Li S, Kamboh MI, Morris J, Sotolongo-Grau O, Katz MJ, Corcoran C, Dunstan M, Braddel A, Thomas C, Meggy A, Marshall R, Gerrish A, Chapman J, Aguilar M, Taylor S, Hill M, Fairén MD, Hodges A, Vellas B, Soininen H, Kloszewska I, Daniilidou M, Uphill J, Patel Y, Hughes JT, Lord J, Turton J, Hartmann AM, Cecchetti R, Fenoglio C, Serpente M, Arcaro M, Caltagirone C, Orfei MD, Ciaramella A, Pichler S, Mayhaus M, Gu W, Lleó A, Fortea J, Blesa R, Barber IS, Brookes K, Cupidi C, Maletta RG, Carrell D, Sorbi S, Moebus S, Urbano M, Pilotto A, Kornhuber J, Bosco P, Todd S, Craig D, Johnston J, Gill M, Lawlor B, Lynch A, Fox NC, Hardy J, Albin RL, Apostolova LG, Arnold SE, Asthana S, Atwood CS, Baldwin CT, Barnes LL, Barral S, Beach TG, Becker JT, Bigio EH, Bird TD, Boeve BF, Bowen JD, Boxer A, Burke JR, Burns JM, Buxbaum JD, Cairns NJ, Cao C, Carlson CS, Carlsson CM, Carney RM, Carrasquillo MM, Carroll SL, Diaz CC, Chui HC, Clark DG, Cribbs DH, Crocco EA, DeCarli C, Dick M, Duara R, Evans DA, Faber KM, Fallon KB, Fardo DW, Farlow MR, Ferris S, Foroud TM, Galasko DR, Gearing M, Geschwind DH, Gilbert JR, Graff-Radford NR, Green RC, Growdon JH, Hamilton RL, Harrell LE, Honig LS, Huentelman MJ, Hulette CM, Hyman BT, Jarvik GP, Abner E, Jin LW, Jun G, Karydas A, Kaye JA, Kim R, Kowall NW, Kramer JH, LaFerla FM, Lah JJ, Leverenz JB, Levey AI, Li G, Lieberman AP, Lunetta KL, Lyketsos CG, Marson DC, Martiniuk F, Mash DC, Masliah E, McCormick WC, McCurry SM, McDavid AN, McKee AC, Mesulam M, Miller BL, Miller CA, Miller JW, Morris JC, Murrell JR, Myers AJ, O''Bryant S, Olichney JM, Pankratz VS, Parisi JE, Paulson HL, Perry W, Peskind E, Pierce A, Poon WW, Potter H, Quinn JF, Raj A, Raskind M, Reisberg B, Reitz C, Ringman JM, Roberson ED, Rogaeva E, Rosen HJ, Rosenberg RN, Sager MA, Saykin AJ, Schneider JA, Schneider LS, Seeley WW, Smith AG, Sonnen JA, Spina S, Stern RA, Swerdlow RH, Tanzi RE, Thornton-Wells TA, Trojanowski JQ, Troncoso JC, Van Deerlin VM, Van Eldik LJ, Vinters HV, Vonsattel JP, Weintraub S, Welsh-Bohmer KA, Wilhelmsen KC, Williamson J, Wingo TS, Woltjer RL, Wright CB, Yu CE, Yu L, Garzia F, Golamaully F, Septier G, Engelborghs S, Vandenberghe R, De Deyn PP, Fernadez CM, Benito YA, Thonberg H, Forsell C, Lilius L, Kinhult-Stählbom A, Kilander L, Brundin R, Concari L, Helisalmi S, Koivisto AM, Haapasalo A, Dermecourt V, Fievet N, Hanon O, Dufouil C, Brice A, Ritchie K, Dubois B, Himali JJ, Keene CD, Tschanz J, Fitzpatrick AL, Kukull WA, Norton M, Aspelund T, Larson EB, Munger R, Rotter JI, Lipton RB, et al. RarView Related Profiles. PMID: 28714976.
  2. Alosco ML, Jarnagin J, Tripodis Y, Martin B, Chaisson C, Baugh CM, Torres A, Nowinski CJ, Cantu RC, Stern RA. Utility of providing a concussion definition in the assessment of concussion history in former NFL players. Brain Inj. 2017; 31(8):1116-1123.View Related Profiles. PMID: 28471243; DOI: 10.1080/02699052.2017.1294709;.
  3. Tripodis Y, Alosco ML, Zirogiannis N, Gavett BE, Chaisson C, Martin B, McClean MD, Mez J, Kowall N, Stern RA. The Effect of Traumatic Brain Injury History with Loss of Consciousness on Rate of Cognitive Decline Among Older Adults with Normal Cognition and Alzheimer''s Disease Dementia. J Alzheimers Dis. 2017; 59(1):251-263.View Related Profiles. PMID: 28655133.
  4. Alosco ML, Duskin J, Besser LM, Martin B, Chaisson CE, Gunstad J, Kowall NW, McKee AC, Stern RA, Tripodis Y. Modeling the Relationships Among Late-Life Body Mass Index, Cerebrovascular Disease, and Alzheimer''s Disease Neuropathology in an Autopsy Sample of 1,421 Subjects from the National Alzheimer''s Coordinating Center Data Set. J Alzheimers Dis. 2017; 57(3):953-968.View Related Profiles. PMID: 28304301; DOI: 10.3233/JAD-161205;.
  5. Zhu H, Stern RA, Tao Q, Bourlas A, Essis MD, Chivukula M, Rosenzweig J, Steenkamp D, Xia W, Mercier GA, Tripodis Y, Farlow M, Kowall N, Qiu WQ. An amylin analog used as a challenge test for Alzheimer''s disease. Alzheimers Dement (N Y). 2017 Jan; 3(1):33-43.View Related Profiles. PMID: 28503657; DOI: 10.1016/j.trci.2016.12.002;.
  6. Alosco ML, Tripodis Y, Jarnagin J, Baugh CM, Martin B, Chaisson CE, Estochen N, Song L, Cantu RC, Jeromin A, Stern RA. Repetitive head impact exposure and later-life plasma total tau in former National Football League players. Alzheimers Dement (Amst). 2017; 7:33-40.View Related Profiles. PMID: 28229128; DOI: 10.1016/j.dadm.2016.11.003;.
  7. Stern RA. Cerebrospinal Fluid Biomarkers in Postconcussion Syndrome: Measuring Neuronal Injury and Distinguishing Individuals at Risk for Persistent Postconcussion Syndrome or Chronic Traumatic Encephalopathy. JAMA Neurol. 2016 Nov 01; 73(11):1280-1282. PMID: 27654455; DOI: 10.1001/jamaneurol.2016.3169;.
  8. Cherry JD, Tripodis Y, Alvarez VE, Huber B, Kiernan PT, Daneshvar DH, Mez J, Montenigro PH, Solomon TM, Alosco ML, Stern RA, McKee AC, Stein TD. Microglial neuroinflammation contributes to tau accumulation in chronic traumatic encephalopathy. Acta Neuropathol Commun. 2016 Oct 28; 4(1):112.View Related Profiles. PMID: 27793189.
  9. Gavett BE, Gurnani AS, Saurman JL, Chapman KR, Steinberg EG, Martin B, Chaisson CE, Mez J, Tripodis Y, Stern RA. Practice Effects on Story Memory and List Learning Tests in the Neuropsychological Assessment of Older Adults. PLoS One. 2016; 11(10):e0164492.View Related Profiles. PMID: 27711147; DOI: 10.1371/journal.pone.0164492;.
  10. Stern RA, Abularach LM, Seichepine DR, Alosco ML, Gavett BE, Tripodis Y. Office-Based Assessment of At-Risk Driving in Older Adults With and Without Cognitive Impairment. J Geriatr Psychiatry Neurol. 2016 Sep 19.View Related Profiles. PMID: 27647790; DOI: 10.1177/0891988716666378;.
Showing 10 of 141 results. Show More

This graph shows the total number of publications by year, by first, middle/unknown, or last author.

Bar chart showing 141 publications over 31 distinct years, with a maximum of 14 publications in 2016

YearPublications
19861
19871
19891
19901
19914
19926
19936
19943
19955
19966
19974
19981
19993
20005
20011
20022
20036
20042
20051
20062
20074
20085
20094
20105
20117
20129
20136
201410
201511
201614
20175
In addition to these self-described keywords below, a list of MeSH based concepts is available here.

Alzheimer's Disease
Chronic Traumatic Encephalopathy
Concussion
Dementia
Neuropsychology
Contact for Mentoring:


72 E. Concord St Robinson (B)
Boston MA 02118
Google Map


Stern's Networks
Click the "See All" links for more information and interactive visualizations
Concepts
_
Co-Authors
_
Similar People
_
Same Department